Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Non-Muscle Invasive Bladder Urothelial Carcinoma × apalutamide × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 5 Prostate Cancer Metastatic Disease 1 Non-Muscle Invasive Bladder Urothelial Carcinoma 1 Neoplasm Metastasis 1

Interventions

apalutamide 1 Transurethral Resection of Bladder 1 Specimen Handling 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05521698 2026-02-17

Study to Determine Possible Effects of Apalutamide, Compared to Placebo, on EGFR Expression in Patients With Non-muscle Invasive Bladder Cancer

University of Wisconsin, Madison

Phase 1 Not yet recruiting

Non-Muscle Invasive Bladder Urothelial Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡